GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harrow Inc (NAS:HROW) » Definitions » Price-to-Operating-Cash-Flow

Harrow (Harrow) Price-to-Operating-Cash-Flow : 117.00 (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Harrow Price-to-Operating-Cash-Flow?

As of today (2024-04-28), Harrow's share price is $10.53. Harrow's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.09. Hence, Harrow's Price-to-Operating-Cash-Flow Ratio for today is 117.00.

The historical rank and industry rank for Harrow's Price-to-Operating-Cash-Flow or its related term are showing as below:

HROW' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 17.65   Med: 105.22   Max: 511.76
Current: 117

During the past 13 years, Harrow's highest Price-to-Operating-Cash-Flow Ratio was 511.76. The lowest was 17.65. And the median was 105.22.

HROW's Price-to-Operating-Cash-Flow is ranked worse than
95.26% of 675 companies
in the Drug Manufacturers industry
Industry Median: 17.14 vs HROW: 117.00

Harrow's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.25. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.09.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Harrow was 90.30% per year.

During the past 13 years, Harrow's highest 3-Year average Operating Cash Flow per Share Growth Rate was 87.10% per year. The lowest was -260.70% per year. And the median was 18.50% per year.


Harrow Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Harrow's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harrow Price-to-Operating-Cash-Flow Chart

Harrow Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 216.11 - 45.47 238.06 94.92

Harrow Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 238.06 - - - 94.92

Competitive Comparison of Harrow's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Harrow's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harrow's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harrow's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Harrow's Price-to-Operating-Cash-Flow falls into.



Harrow Price-to-Operating-Cash-Flow Calculation

Harrow's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=10.53/0.09
=117.00

Harrow's Share Price of today is $10.53.
Harrow's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Harrow Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Harrow's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Harrow (Harrow) Business Description

Industry
Traded in Other Exchanges
N/A
Address
102 Woodmont Boulevard, Suite 610, Nashville, TN, USA, 37205
Harrow Inc is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year.
Executives
Mark L Baum director, 10 percent owner, officer: Chief Executive Officer C/O IMPRIMIS PHARMACEUTICALS, INC, 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130
Opaleye Management Inc. 10 percent owner ONE BOSTON PLACE, SUITE 2600, BOSTON MA 02108
Martin A. Makary director 102 WOODMONT BLVD., SUITE 610, NASHVILLE TN 37205
Van Horn R. Lawrence director 354 COOL SPRINGS BLVD., SUITE 106, FRANKLIN TN 37067
Andrew Boll officer: VP, Accounting and Reporting 437 S HWY 101, STE 209, SOLANA BEACH CA 92075
Lindstrom Richard L Md director 2811 WESTWOOD PL, WAYZATA MN 55391
Perry J. Sternberg director 102 WOODMONT BLVD., SUITE 610, NASHVILLE TN 37205
Teresa Sparks director 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Robert J Kammer director, 10 percent owner, officer: Chairman of the Board 1440 28TH STREET, SUITE 9, BOULDER CO 80303
Longboard Capital Advisors, Llc other: Institutional Investor 9665 WILSHIRE BLVD., SUITE 430, BEVERLY HILLS CA 90212
Brett Conrad other: Managing Mbr of Longboard Cap. 1312 CEDAR ST., SANTA MONICA CA 90405
Clayton D Edwards officer: Chief Operating Officer 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130
Anthony Principi director 2300 WEST PLANO PARKWAY, M/S D2420, PLANO TX 75244
Donald Paul Miloni 10 percent owner 1425 GREENWOOD LANE, GREENWOOD VILLAGE CO 80125
John P. Saharek officer: Chief Commercial Officer 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130